▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3963 by analyst upside · 2026-09-27
PFE
Pfizer Inc.
Healthcare · Market Cap $163B · P/E 37.7x
ANALYST PRICE TARGET
+0.7%
implied upside to consensus target
Current Price $28.67
Consensus Target $28.88
Bull Target $35.75
Bear Target $25.0
Analysts Covering 26
ANALYST CONSENSUS - HOLD
Strong Buy
2
Buy
7
Hold
15
Sell
2
52-Week Low $23.62
52-Week High $29.21
YTD Return +19.7%
FUNDAMENTALS
Market Cap $163B
P/E Ratio (TTM) 37.7x
Forward P/E 9.9x
EPS (TTM) $0.76
PEG Ratio 13.11
Dividend Yield 6.00%
Revenue (TTM) $63.7B
Profit Margin 6.8%
52-WEEK RANGE
52-Week Low $23.62
52-Week High $29.21
Current Price $28.67
Bear Target $25.0
Bull Target $35.75
● Now $28.67 ● Target $28.88
TRADING DATA
Avg Volume 38.2M
YTD Return +19.7%
Analyst Count 26
Consensus Hold
Upside to Target +0.7%
Last Updated 2026-09-27

ANALYST SUMMARY

Pfizer Inc. (PFE) is currently trading at $28.67 with a Wall Street consensus price target of $28.88, implying potential upside of 0.7% over the next 12 months. 26 analysts currently cover PFE, with a consensus rating of Hold - 35% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.75, while the most cautious has a target of $25.0.

PFE operates in the Healthcare sector with a market capitalisation of $163B. The stock is up 19.7% year-to-date and is currently trading near the upper end of its 52-week range of $23.62 – $29.21.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PFE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HSBC - Reiterated
Hold → Hold 2026-09-10 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-08-07 62% win rate (8 calls)
BMO Capital - Reiterated
Outperform → Outperform 2026-07-13 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-07-13 62% win rate (8 calls)
B of A Securities - Reiterated
Neutral → Neutral 2026-07-10 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-07-08 43% win rate (7 calls)
Cantor Fitzgerald reit
Neutral → Neutral 2026-07-06 40% win rate (10 calls)
HSBC ↓ Downgrade
Buy → Hold 2026-07-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
50
out of 100
Coverage depth
25/30
Consensus clarity
23/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →